BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34851502)

  • 61. Clinical Outcomes of Computed Tomography-Based Volumetric Brachytherapy Planning for Cervical Cancer.
    Simpson DR; Scanderbeg DJ; Carmona R; McMurtrie RM; Einck J; Mell LK; McHale MT; Saenz CC; Plaxe SC; Harrison T; Mundt AJ; Yashar CM
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):150-7. PubMed ID: 26130230
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A feasibility study of using advanced external beam techniques to create a vaginal cuff brachytherapy-like endometrial boost plan.
    Grelewicz Z; Zerrusen B; Sathiaseelan V; Zhang H
    Med Dosim; 2018 Spring; 43(1):30-38. PubMed ID: 28886961
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Salvage high-dose-rate brachytherapy for isolated vaginal recurrence of endometrial cancer.
    Baek S; Isohashi F; Yamaguchi H; Mabuchi S; Yoshida K; Kotsuma T; Yamazaki H; Tanaka E; Sumida I; Tamari K; Otani K; Seo Y; Suzuki O; Yoshioka Y; Kimura T; Ogawa K
    Brachytherapy; 2016; 15(6):812-816. PubMed ID: 27614661
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
    Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Volumetric image guidance for intravaginal brachytherapy: A dosimetric and clinical study.
    Udayashankara AH; Srikantia N; Muzumder S; Chandramouli SH; Raj JM; Shariff MH
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S320-S327. PubMed ID: 36510983
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?
    Ager BJ; Francis SR; Do OA; Huang YJ; Soisson AP; Dodson MK; Werner TL; Sause WT; Grant JD; Gaffney DK
    Brachytherapy; 2019; 18(4):453-461. PubMed ID: 31005603
    [TBL] [Abstract][Full Text] [Related]  

  • 67. External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis.
    Narasimhulu DM; Cope A; Riaz IB; Petersen I; Cilby W; Langstraat C; Glaser G; Kumar A; Cappuccio S; Murad MH; West C; Mariani A
    Int J Gynecol Cancer; 2020 Jun; 30(6):797-805. PubMed ID: 32221021
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
    Martinez AA; Kestin LL; Stromberg JS; Gonzalez JA; Wallace M; Gustafson GS; Edmundson GK; Spencer W; Vicini FA
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):343-52. PubMed ID: 10802358
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Brachytherapy for endometrial cancers].
    Charra-Brunaud C; Mazeron R
    Cancer Radiother; 2013 Apr; 17(2):106-10. PubMed ID: 23375394
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
    Lee LJ; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy.
    Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1366-72. PubMed ID: 12873682
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
    Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical outcomes and dosimetric predictors of toxicity for re-irradiation of vaginal recurrence of endometrial cancer.
    Lee LJ; Alban GM; Cheng T; Buzurovic I; Pretz J; Singer L; King MT
    Brachytherapy; 2022; 21(3):263-272. PubMed ID: 35078717
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
    Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Three-dimension anatomy-based planning optimization for high dose rate vaginal vault brachytherapy.
    Bahadur YA; Hassouna AH; Constantinescu CT; Naga AF; Ghasal NM; Elsayed ME
    Saudi Med J; 2012 Jun; 33(6):640-7. PubMed ID: 22729119
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Image-guided high-dose-rate brachytherapy in inoperable endometrial cancer.
    Dankulchai P; Petsuksiri J; Chansilpa Y; Hoskin PJ
    Br J Radiol; 2014 Jul; 87(1039):20140018. PubMed ID: 24807067
    [TBL] [Abstract][Full Text] [Related]  

  • 78. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
    Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dose volume analysis of radiotherapy for inoperable patients with stage I-II endometrial carcinoma.
    Ohkubo Y; Kato S; Kiyohara H; Tsuruoka I; Tamaki T; Noda SE; Ohno T; Nakano T
    J Radiat Res; 2011; 52(5):666-73. PubMed ID: 21857147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.